Table 4.
Group | IL-1β (pg/mL) | IL-6 (pg/mL) | TNF-α (pg/mL) | IFN-γ (pg/mL) |
---|---|---|---|---|
Normal | 47.3±3.7a | 89.1±10.1a | 333±13a | 426±16a |
Model | 79.6±2.6b | 149.8±11.2b | 531±34b | 662±47b |
Silymarin | 60.6±2.6c | 98.1±7.4ac | 373±14c | 459±39ac |
GPFE-H | 52.8±4.3d | 97.0±6.8ac | 445±17d | 459±29ac |
GPFE-L | 64.5±2.8c | 101.6±4.9c | 475±12e | 505±32c |
Notes: Values are presented as the mean ± standard deviation (n = 8/group). Silymarin, mice treated with 200 mg/kg silymarin; GPFE-H, mice treated with 300 mg/kg GPFE; GPFE-L, mice treated with 150 mg/kg GPFE. a–eMean values with different letters in the same column are significantly different (P < 0.05) based on Tukey’s test.